24,352 results
Search Results
102. An Investigation into the Water Retention Behaviour of an Unsaturated Natural Fissured Clay.
- Author
-
Pedone, Giuseppe, Cotecchia, Federica, Tagarelli, Vito, Bottiglieri, Osvaldo, and Murthy, Madhusudhan B. N.
- Subjects
CLAY ,CLAY soils ,SOIL cracking ,SCANNING electron microscopes ,FILTER paper ,RAINFALL - Abstract
The presence of intensely fissured soils is often found to relate to high geotechnical risks, such as landslide risk. This is especially the case of the Southern Apennines, Italy, where slopes formed of intensely fissured clays are frequently affected by landslides. The latter are generally triggered by rainfall infiltration, which takes place through the outcropping, unsaturated clayey soil cover. With the final aim of reducing landslide risk in areas covered by fissured clays, a detailed hydro-mechanical characterisation of these materials is required. While the behaviour of fully saturated fissured clays has been investigated in the last decade, only a few studies dealing with unsaturated, natural fissured clays are reported in the literature. The present paper aims to give a contribution toward filling this gap by extending an investigation campaign started a few years ago on the Paola Doce fissured clay outcropping on the Pisciolo slope (Southern Apennines, Italy). The physical properties of the material and some of its key micro- to meso-structural features are first analysed, the latter also based on Scanning Electron Microscope (SEM) micrographs of an undisturbed sample taken at 1.4 m depth on the Pisciolo slope, which is mainly formed of Paola Doce clay. Subsequently, water retention data of the soil are presented, which were obtained using both high-capacity tensiometers and the filter paper technique. These data were collected not only on undisturbed samples but also while subjecting the same material to drying paths. The results herein reported aim to make a link between the water retention behaviour of the Paola Doce clay sampled at Pisciolo and its fissured structure. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
103. Complementary feeding in preterm infants: a position paper by Italian neonatal, paediatric and paediatric gastroenterology joint societies.
- Author
-
Baldassarre, Maria Elisabetta, Panza, Raffaella, Cresi, Francesco, Salvatori, Guglielmo, Corvaglia, Luigi, Aceti, Arianna, Giannì, Maria Lorella, Liotto, Nadia, Ilardi, Laura, Laforgia, Nicola, Maggio, Luca, Lionetti, Paolo, Agostoni, Carlo, Orfeo, Luigi, Di Mauro, Antonio, Staiano, Annamaria, and Mosca, Fabio
- Subjects
- *
INFANTS , *BREAST milk , *NUTRITIONAL requirements , *PEDIATRICS , *LOW birth weight , *BREASTFEEDING , *INFANT weaning - Abstract
Nutrition in the first 1000 days of life is essential to ensure appropriate growth rates, prevent adverse short- and long-term outcomes, and allow physiologic neurocognitive development. Appropriate management of early nutritional needs is particularly crucial for preterm infants. Although the impact of early nutrition on health outcomes in preterm infants is well established, evidence-based recommendations on complementary feeding for preterm neonates and especially extremely low birth weight and extremely low gestational age neonates are still lacking. In the present position paper we performed a narrative review to summarize current evidence regarding complementary feeding in preterm neonates and draw recommendation shared by joint societies (SIP, SIN and SIGENP) for paediatricians, healthcare providers and families with the final aim to reduce the variability of attitude and timing among professionals. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
104. Diagnostic therapeutic care pathway for pediatric food allergies and intolerances in Italy: a joint position paper by the Italian Society for Pediatric Gastroenterology Hepatology and Nutrition (SIGENP) and the Italian Society for Pediatric Allergy and Immunology (SIAIP)
- Author
-
Berni Canani, Roberto, Caffarelli, Carlo, Calvani, Mauro, Martelli, Alberto, Carucci, Laura, Cozzolino, Tommaso, Alvisi, Patrizia, Agostoni, Carlo, Lionetti, Paolo, and Marseglia, Gian Luigi
- Subjects
- *
TREATMENT of food intolerance , *DIAGNOSIS of food allergies , *SKIN tests , *FOOD intolerance , *PEDIATRICS , *HEALTH care teams , *PROFESSIONAL associations , *FOOD allergy , *IMMUNOTHERAPY , *SYMPTOMS , *CHILDREN - Abstract
Epidemiologic data suggest an increased prevalence of pediatric food allergies and intolerances (FAIs) during the last decades. This changing scenario has led to an increase in the overall healthcare costs, due to a growing demand for diagnostic and treatment services. There is the need to establish Evidence-based practices for diagnostic and therapeutic intervention that could be adopted in the context of public health policies for FAIs are needed. This joint position paper has been prepared by a group of experts in pediatric gastroenterology, allergy and nutrition from the Italian Society for Pediatric Gastroenterology Hepatology and Nutrition (SIGENP) and the Italian Society for Pediatric Allergy and Immunology (SIAIP). The paper is focused on the Diagnostic Therapeutic Care Pathway (DTCP) for pediatric FAIs in Italy. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
105. [ANMCO Position paper: Diagnostic and therapeutic pathways in patients with hypercholesterolemia and statin intolerance].
- Author
-
Gulizia MM, Colivicchi F, Arca M, Abrignani MG, Perna GP, Mureddu GF, Nardi F, and Riccio C
- Subjects
- Algorithms, Anticholesteremic Agents therapeutic use, Clinical Trials as Topic, Humans, Hypercholesterolemia blood, Italy, Risk Assessment, Risk Factors, Cholesterol, LDL blood, Cholesterol, LDL drug effects, Hydroxymethylglutaryl-CoA Reductase Inhibitors adverse effects, Hypercholesterolemia drug therapy
- Abstract
Statins are a class of drugs registered and prescribed to lower total and LDL-cholesterol. Clinical trials performed in the last 25 years have shown that these agents are effective in improving cardiovascular outcomes in several different clinical settings. However, in some cases statin treatment may be associated with significant side effects and adverse reactions. The occurrence of such adverse events during statin therapy may cause discontinuation of treatment together with the impossibility of achieving recommended lipid goals. The clinical condition in which patients experience major unacceptable symptoms and/or develop laboratory abnormalities during statin therapy is defined as statin intolerance. This document outlines the diagnostic and therapeutic pathways for the clinical management of patients with hypercholesterolemia and statin intolerance.
- Published
- 2016
- Full Text
- View/download PDF
106. [ANMCO Position paper: Clinical management of hypercholesterolemia in patients with acute coronary syndrome].
- Author
-
Colivicchi F, Gulizia MM, Arca M, Abrignani MG, Perna GP, Mureddu GF, Nardi F, and Riccio C
- Subjects
- Acute Coronary Syndrome blood, Anticholesteremic Agents therapeutic use, Cholesterol, LDL blood, Drug Therapy, Combination, Ezetimibe therapeutic use, Humans, Hypercholesterolemia blood, Italy, Treatment Outcome, Acute Coronary Syndrome drug therapy, Cholesterol, LDL drug effects, Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use, Hypercholesterolemia drug therapy
- Abstract
LDL-cholesterol (LDL-C) reduction after acute coronary syndromes (ACS) is associated with a significant reduction in ischemic recurrences. Accordingly, international guidelines recommend a reduction of LDL-C below 70 mg/dl in ACS patients. Such a result can be accomplished by using high intensity statins, possibly associated with ezetimibe in selected cases. This document outlines the management strategies that can be consistently implemented in clinical practice in order to achieve and maintain guideline-recommended therapeutic goals.
- Published
- 2016
- Full Text
- View/download PDF
107. [Remarks on polyparametric assessment of sudden death risk for primary prevention ICD implantation in patients with left ventricular dysfunction of ischemic and non ischemic etiology. Italian Association of Hospital Cardiologists (ANMCO) Experts Position Paper].
- Author
-
Disertori M, Gulizia MM, Casolo G, Delise P, Di Lenarda A, Di Tano G, Lunati M, Mestroni L, Salerno-Uriarte JA, and Tavazzi L
- Subjects
- Humans, Italy, Patient Selection, Practice Guidelines as Topic, Primary Prevention methods, Risk Assessment methods, Sensitivity and Specificity, Ventricular Dysfunction, Left complications, Death, Sudden, Cardiac prevention & control, Defibrillators, Implantable, Ventricular Dysfunction, Left therapy
- Abstract
It is generally recognized that current guidelines, based on ejection fraction criteria, do not allow appropriate selection of patients for implantable cardioverter-defibrillator (ICD) therapy in the primary prevention of sudden death, thus hindering the optimal use of ICD in patients with left ventricular dysfunction of ischemic and nonischemic etiology. Ejection fraction alone has limitations in both sensitivity and specificity. Assessment of the risk for sudden death using a combination of multiple tests (ejection fraction associated with one or more different arrhythmic risk markers) could partially compensate for these limitations. In this position paper, the potential usefulness of a polyparametric assessment using some of the most investigated risk markers of sudden death is discussed, including late gadolinium enhancement cardiac magnetic resonance, programmed ventricular stimulation, T-wave alternans, autonomic tone, biomarkers, and genetic testing.
- Published
- 2015
- Full Text
- View/download PDF
108. Geographic Distribution, Number, and Types of Papers Published in International Cytopathology Journals in the Last 5.5 Years: A Preliminary Study.
- Author
-
Yaprak Bayrak B and Paksoy N
- Subjects
- China, Germany, Humans, Italy, Spain, Periodicals as Topic
- Abstract
Objective: The aim of this study was to explore the geographic distribution and number of papers published in international and Science Citation Index (SCI)-indexed cytology journals based on their country of origin., Materials and Methods: A country-based geographic analysis of studies published over a 5.5-year period from January 2016 to June 2021 in 5 cytopathology journals indexed as SCI and SCI-E with an impact factor higher than 1 (Cancer Cytopathology, Cytopathology, Diagnostic Cytopathology, Acta Cytologica, and CytoJournal) and papers categorized as "original" and "other" was performed., Results: A total of 3,063 papers were found, with 1,466 (47.8%) categorized as "original" papers and 1,597 (52.1%) designated as "other" papers. These papers were submitted from 62 different countries. The five countries with the greatest number of papers were the USA (38.4%), India (16.8%), Japan (7.4%), Italy (5.5%), and Brazil (3.1%). A general subgroup analysis was also performed on the original studies without a country breakdown. Cytomorphological, cytomorphological-immunohistochemical, and molecular assessments compose 38.5%, 45.7%, and 15% of the subgroups, respectively., Conclusion: The number of academic papers originating from developing countries in the field of cytopathology has increased in recent years. Although most scientific papers are produced in developed countries, the rate in these countries is much lower than that in some developing countries as the rate of academic growth in developed countries has stabilized. Despite the widespread and sophisticated implementation of cytology in daily practice in Western European countries outside the UK, such as Germany and the Netherlands, and in Scandinavian countries and other developed countries, such as Australia and Canada, these countries rank in the middle to lower end of countries producing cytology papers. Meanwhile, there has been an increase in the number of cytology papers published by authors from Southern European countries, such as Italy (ranked 4th) and Spain (ranked 6th), and Turkey (ranked 8th). There is a remarkable increase in cytology papers originating from Asia, particularly India, Japan, and China., Summary: We aimed to present a basic survey of the geographic distribution of manuscript submissions to high-impact cytopathology journals and to point out emerging trends in cytology utilization and basic research. However, our results show that the landscape of cytology is changing and suggest geographic regions that are ripe for the production of novel "points of view" and new research findings., (© 2022 S. Karger AG, Basel.)
- Published
- 2022
- Full Text
- View/download PDF
109. Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies.
- Author
-
Russo A, Incorvaia L, Capoluongo E, Tagliaferri P, Gori S, Cortesi L, Genuardi M, Turchetti D, De Giorgi U, Di Maio M, Barberis M, Dessena M, Del Re M, Lapini A, Luchini C, Jereczek-Fossa BA, Sapino A, and Cinieri S
- Subjects
- Female, Humans, Italy, Male, Societies, Scientific, Ovarian Neoplasms diagnosis, Ovarian Neoplasms genetics, Ovarian Neoplasms prevention & control, Pancreatic Neoplasms, Prostatic Neoplasms diagnosis, Prostatic Neoplasms genetics, Prostatic Neoplasms therapy
- Abstract
Constitutional BRCA1/BRCA2 pathogenic or likely pathogenic variants (PVs) are associated with an increased risk for developing breast and ovarian cancers. Current evidence indicates that BRCA1/2 PVs are also associated with pancreatic cancer, and that BRCA2 PVs are associated with prostate cancer risk. The identification of carriers of constitutional PVs in the BRCA1/2 genes allows the implementation of individual and family prevention pathways, through validated screening programs and risk-reducing strategies. According to the relevant and increasing therapeutic predictive implications, the inclusion of BRCA testing in the routine management of patients with breast, ovarian, pancreatic and prostate cancers represent a key requirement to optimize medical or surgical therapeutic and prevention decision-making, and access to specific anticancer therapies. Therefore, accurate patient selection, the use of standardized and harmonized procedures, and adherence to homogeneous testing criteria, are essential elements to implement BRCA testing in clinical practice. This consensus position paper has been developed and approved by a multidisciplinary Expert Panel of 64 professionals on behalf of the AIOM-AIRO-AISP-ANISC-AURO-Fondazione AIOM-SIAPEC/IAP-SIBioC-SICO-SIF-SIGE-SIGU-SIU-SIURO-UROP Italian Scientific Societies, and a patient association (aBRCAdaBRA Onlus). The working group included medical, surgical and radiation oncologists, medical and molecular geneticists, clinical molecular biologists, surgical and molecular pathologists, organ specialists such as gynecologists, gastroenterologists and urologists, and pharmacologists. The manuscript is based on the expert consensus and reports the best available evidence, according to the current eligibility criteria for BRCA testing and counseling, it also harmonizes with current Italian National Guidelines and Clinical Recommendations., Competing Interests: Disclosure LC: honoraria for presentations from Astra Zeneca, Pfizer, Novartis, MSD; support for attending meetings from AstraZeneca; advisory board of Astra Zeneca, Novartis, MSD, Gilead. UDG: consulting fees from AstraZeneca, Pfizer, MSD, BMS, Ipsen, Novartis, Astellas, Janssen, Bayer, PharmaMar, Eisai, and Clovis. MDM: grants from any entity from Tesaro, GlaxoSmithKline; consulting fees from Novartis, Roche, AstraZeneca, Merck Serono, Pfizer, Merck Sharp & Dohme, Janssen, Eisai, Takeda, Boehringer Ingelheim, and Servier; honoraria for presentations from Novartis, Roche, AstraZeneca, Pfizer, Merck Sharp & Dohme, Janssen, Astellas, Boehringer Ingelheim; serves on the advisory board of Merck Sharp & Dohme, Amgen, Janssen, and Astellas. MG: honoraria for presentations from MSD. BAJF: honoraria for presentations from Janssen, Ferring, Bayer, Roche, Astellas, Elekta, Carl Zeiss, Ipsen, Accuray, and IBA. AL: consulting fees from Astellas, Jansen, and Bayer. AR: advisory boards of Bristol, Pfizer, Bayer, Kyowa Kirin, Ambrosetti; and honoraria for presentations from Roche Diagnostic and AstraZeneca. All other authors have declared no conflicts of interest., (Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
110. Non-high-density lipoprotein cholesterol versus low-density lipoprotein cholesterol in clinical practice: ANMCO position paper.
- Author
-
Colivicchi F, Di Fusco SA, Arca M, Leggio M, Caldarola P, Murrone A, Valente S, Urbinati S, Roncon L, Amodeo V, Aspromonte N, Cipriani M, Domenicucci S, Francese GM, Imazio M, di Uccio FS, Di Lenarda A, Gulizia MM, and Gabrielli D
- Subjects
- Cardiometabolic Risk Factors, Cholesterol, HDL blood, Humans, Italy, Preventive Health Services methods, Standard of Care, Triglycerides blood, Atherosclerosis blood, Atherosclerosis prevention & control, Cardiovascular Diseases blood, Cardiovascular Diseases prevention & control, Cholesterol analysis, Cholesterol metabolism, Cholesterol, LDL blood, Hypolipidemic Agents pharmacology, Risk Assessment methods
- Abstract
Bloodstream cholesterol is a central contributor to atherosclerotic cardiovascular diseases. For several decades, low-density lipoprotein cholesterol (LDL-C) has been the main biomarker for the prediction of cardiovascular events and therapeutic target of lipid-lowering treatments. More recently, several findings have supported the greater reliability of non-high-density lipoprotein cholesterol (non-HDL-C) as a predictive factor and possible therapeutic target in refining antiatherogenic treatments, especially among patients with lower LDL-C and higher triglyceride values. This article discusses the limits of current standard methods for assessing LDL-C levels and emphasizes the persistent residual cardiovascular risk in patients treated with lipid-lowering agents on the basis of recommended LDL-C targets. It highlights that patients with controlled LDL-C and non-targeted non-HDL-C have a higher cardiovascular risk. The article focuses on the role of non-HDL-C as a better predictor of atherosclerotic disease as compared with LDL-C and as a therapeutic target. Finally, this article includes an executive summary aimed at refining preventive approaches in atherosclerotic cardiovascular disease., (Copyright © 2021 Italian Federation of Cardiology - I.F.C. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
111. Appropriate use criteria for cardiovascular MRI: SIC - SIRM position paper Part 2 (myocarditis, pericardial disease, cardiomyopathies and valvular heart disease).
- Author
-
Francone M, Aquaro GD, Barison A, Castelletti S, de Cobelli F, de Lazzari M, Esposito A, Focardi M, di Renzi P, Indolfi C, Lanzillo C, Lovato L, Maestrini V, Mercuro G, Natale L, Mantini C, Polizzi G, Rabbat M, Secchi F, Secinaro A, di Cesare E, and Pontone G
- Subjects
- Data Accuracy, Humans, Italy, Prognosis, Quality Improvement, Societies, Medical, Cardiology methods, Cardiology standards, Cardiology trends, Cardiomyopathies diagnosis, Heart Valve Diseases diagnosis, Magnetic Resonance Imaging, Cine methods, Myocarditis diagnosis, Pericarditis diagnosis, Radiology methods, Radiology standards, Radiology trends
- Abstract
Cardiovascular magnetic resonance (CMR) has emerged as an accurate diagnostic technique for the evaluation of patients with cardiac disease in the majority of clinical settings, thanks to an established additional diagnostic and prognostic value. This document has been developed by a joined group of experts of the Italian Society of Cardiology (SIC) and Italian Society of Radiology (SIRM) to provide a summary about the current state of technology and clinical applications of CMR, to improve the clinical diagnostic pathways and to promote its inclusion in clinical practice. The writing committee consisted of members and experts of both societies in order to develop a more integrated approach in the field of cardiac imaging. This section 2 will cover myocarditis, pericardial disease, cardiomyopathies and valvular heart disease., (Copyright © 2021 Italian Federation of Cardiology - I.F.C. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
112. Joint Statement on the Role of Respiratory Rehabilitation in the COVID-19 Crisis: The Italian Position Paper.
- Author
-
Vitacca, Michele, Carone, Mauro, Clini, Enrico Maria, Paneroni, Mara, Lazzeri, Marta, Lanza, Andrea, Privitera, Emilia, Pasqua, Franco, Gigliotti, Francesco, Castellana, Giorgio, Banfi, Paolo, Guffanti, Enrico, Santus, Pierachille, and Ambrosino, Nicolino
- Subjects
- *
CONSENSUS (Social sciences) , *EMPLOYEE recruitment , *EPIDEMICS , *WORKING hours , *INTENSIVE care units , *LABOR supply , *MEDICAL protocols , *NURSES , *PHYSICAL therapy , *PHYSICIANS , *PROFESSIONS , *RESPIRATORY diseases , *COVID-19 - Abstract
Due to the exponential growth of the number of subjects affected by coronavirus disease 2019 (COVID-19), the entire Italian health care system had to respond promptly and in a very short time with the need of semi-intensive and intensive care units. Moreover, trained dedicated COVID-19 teams consisting of physicians were coming from different specialties (intensivists or pneumologists and infectiologists), while respiratory therapists and nurses have been recruited to work on and on without rest. However, due to still limited and evolving knowledge of COVID-19, there are few recommendations concerning the need in respiratory rehabilitation and physiotherapy interventions. The presentation of this paper is the result of a consensus promoted by the Italian societies of respiratory health care professionals who contacted pulmonologists directly involved in the treatment and rehabilitation of COVID-19. The aim was to formulate the more proper and common suggestions to be applied in different hospital settings in offering rehabilitative programs and physiotherapy workforce planning for COVID-19 patients. Two main areas of intervention were identified: organization and treatment, which are described in this paper to face the emergency. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
113. Treatment of children with COVID-19: update of the Italian Society of Pediatric Infectious Diseases position paper.
- Author
-
Venturini E, Montagnani C, Garazzino S, Donà D, Pierantoni L, Lo Vecchio A, Krzysztofiak A, Nicolini G, Bianchini S, Galli L, Villani A, and Gattinara GC
- Subjects
- COVID-19 epidemiology, Child, Female, Humans, Italy, Male, Practice Guidelines as Topic, COVID-19 therapy, Disease Management, Infectious Disease Medicine, Periodicals as Topic, SARS-CoV-2, Societies, Medical
- Published
- 2021
- Full Text
- View/download PDF
114. Management of DOAC in Patients Undergoing Planned Surgery or Invasive Procedure: Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA) Position Paper.
- Author
-
Squizzato A, Poli D, Barcellona D, Ciampa A, Grandone E, Manotti C, Moia M, Toschi V, Tosetto A, and Testa S
- Subjects
- Elective Surgical Procedures methods, Humans, Italy, Patient Care Management methods, Patient Care Management standards, Perioperative Care methods, Perioperative Care standards, Risk Adjustment methods, Risk Adjustment organization & administration, Vitamin K antagonists & inhibitors, Anticoagulants administration & dosage, Anticoagulants adverse effects, Antithrombins administration & dosage, Antithrombins adverse effects, Elective Surgical Procedures adverse effects, Hematologic Tests methods, Postoperative Hemorrhage etiology, Postoperative Hemorrhage prevention & control, Thrombosis diagnosis, Thrombosis prevention & control
- Abstract
Patients on anticoagulant treatment are constantly increasing, with an estimated prevalence in Italy of 2% of the total population. About a quarter of the anticoagulated patients require temporary cessation of direct oral anticoagulants (DOACs) or vitamin K antagonists for a planned intervention within 2 years from anticoagulation inception. Several clinical issues about DOAC interruption remain unanswered: many questions are tentatively addressed daily by thousands of physicians worldwide through an experience-based balancing of thrombotic and bleeding risks. Among possible valuable answers, the Italian Federation of Centers for the diagnosis of thrombotic disorders and the Surveillance of the Antithrombotic therapies (FCSA) proposes some experience-based suggestions and expert opinions. In particular, FCSA provides practical guidance on the following issues: (1) multiparametric assessment of thrombotic and bleeding risks based on patients' individual and surgical risk factor, (2) testing of prothrombin time, activated partial thromboplastin time, and DOAC plasma levels before surgery or invasive procedure, (3) use of heparin, (4) restarting of full-dose DOAC after high risk bleeding surgery, (5) practical nonpharmacological suggestions to manage patients perioperatively. Finally, FCSA suggests creating a multidisciplinary "anticoagulation team" with the aim to define the optimal perioperative management of anticoagulation., Competing Interests: A.S.: Honoraria for lectures, manuscript writing, and/or participation on advisory board from Daiichi Sankyo, Bayer, Pfizer, Bristol-Myers Squibb, Sanofi, Werfen, Alexion, and Roche. D.P.: Honoraria for a webinar from Daiichi Sankyo. D.B.: Honoraria for lectures from Aspen and Werfen. A.C.: Honoraria for lectures from Bayer. E.G.: Honoraria for lectures from Sanofi and Italfarmaco, and for participation on advisory board from Roche, Sanofi Genzyme, and Novo Nordisk. C.M.: None. M.M.: Honoraria for lectures and manuscript writing from Daiichi-Sankyo. V.T.: Honoraria for lectures from Bayer and Novo Nordisk. A.T.: Honoraria for lectures from Werfen, Stago, and Roche; support for attending meetings from Novo Nordisk; honoraria for participation on advisory board from Bayer and Novo Nordisk. S.T.: Honoraria for lectures and for participation on advisory board from Werfen, Stago, Italfarmaco, Pfizer, Bristol-Myers Squibb, and Sanofi., (The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).)
- Published
- 2022
- Full Text
- View/download PDF
115. Recommendations on Complementary Feeding as a Tool for Prevention of Non-Communicable Diseases (NCDs)-Paper Co-Drafted by the SIPPS, FIMP, SIDOHaD, and SINUPE Joint Working Group.
- Author
-
Caroli M, Vania A, Verga MC, Di Mauro G, Bergamini M, Cuomo B, D'Anna R, D'Antonio G, Dello Iacono I, Dessì A, Doria M, Fanos V, Fiore M, Francavilla R, Genovesi S, Giussani M, Gritti A, Iafusco D, Leonardi L, Miniello VL, Miraglia Del Giudice E, Palma F, Pastore F, Scotese I, Simeone G, Squicciarini M, Tezza G, Troiano E, and Umano GR
- Subjects
- Breast Feeding, Delphi Technique, Dietary Carbohydrates administration & dosage, Dietary Fats administration & dosage, Dietary Proteins administration & dosage, Humans, Infant, Italy, Infant Nutritional Physiological Phenomena, Noncommunicable Diseases prevention & control, Societies, Medical
- Abstract
Adequate and balanced nutrition is essential to promote optimal child growth and a long and healthy life. After breastfeeding, the second step is the introduction of complementary feeding (CF), a process that typically covers the period from 6 to 24 months of age. This process is, however, still highly controversial, as it is heavily influenced by socio-cultural choices, as well as by the availability of specific local foods, by family traditions, and pediatrician beliefs. The Società Italiana di Pediatria Preventiva e Sociale (SIPPS) together with the Federazione Italiana Medici Pediatri (FIMP), the Società Italiana per lo Sviluppo e le Origine della Salute e delle Malattie (SIDOHaD), and the Società Italiana di Nutrizione Pediatrica (SINUPE) have developed evidence-based recommendations for CF, given the importance of nutrition in the first 1000 days of life in influencing even long-term health outcomes. This paper includes 38 recommendations, all of them strictly evidence-based and overall addressed to developed countries. The recommendations in question cover several topics such as the appropriate age for the introduction of CF, the most appropriate quantitative and qualitative modalities to be chosen, and the relationship between CF and the development of Non-Communicable Diseases (NCDs) later in life.
- Published
- 2022
- Full Text
- View/download PDF
116. The challenge of the Molecular Tumor Board empowerment in clinical oncology practice: A Position Paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIC-SIF-SIGU-SIRM Italian Scientific Societies.
- Author
-
Russo A, Incorvaia L, Capoluongo E, Tagliaferri P, Galvano A, Del Re M, Malapelle U, Chiari R, Conte P, Danesi R, Fassan M, Ferrara R, Genuardi M, Ghiorzo P, Gori S, Guadagni F, Marchetti A, Marchetti P, Midiri M, Normanno N, Passiglia F, Pinto C, Silvestris N, Tallini G, Vatrano S, Vincenzi B, Cinieri S, and Beretta G
- Subjects
- Genomics, Humans, Italy, Medical Oncology, Neoplasms drug therapy, Neoplasms genetics, Societies, Scientific
- Abstract
The development of innovative technologies and the advances in the genetics and genomics, have offered new opportunities for personalized treatment in oncology. Although the selection of the patient based on the molecular characteristics of the neoplasm has the potential to revolutionize the therapeutic scenario of oncology, this approach is extremely challenging. The access, homogeneity, and economic sustainability of the required genomic tests should be warranted in the clinical practice, as well as the specific scientific and clinical expertise for the choice of medical therapies. All these elements make essential the collaboration of different specialists within the Molecular Tumor Boards (MTBs). In this position paper, based on experts' opinion, the AIOM-SIAPEC/IAP-SIBioC-SIC-SIF-SIGU-SIRM Italian Scientific Societies critically discuss the available molecular profiling technologies, the proposed criteria for the selection of patients candidate for evaluation by the MTB, the criteria for the selection and analysis of biological samples, and the regulatory and pharmaco-economic issues., (Copyright © 2021. Published by Elsevier B.V.)
- Published
- 2022
- Full Text
- View/download PDF
117. Alcohol use disorder in the COVID-19 era: Position paper of the Italian Society on Alcohol (SIA).
- Author
-
Testino G, Vignoli T, Patussi V, Allosio P, Amendola MF, Aricò S, Baselice A, Balbinot P, Campanile V, Fanucchi T, Macciò L, Meneguzzi C, Mioni D, Parisi M, Renzetti D, Rossin R, Gandin C, Bottaro LC, Caio G, Lungaro L, Zoli G, Scafato E, and Caputo F
- Subjects
- Alcoholics Anonymous, Alcoholism epidemiology, Ambulatory Care organization & administration, COVID-19 epidemiology, COVID-19 Vaccines therapeutic use, Delivery of Health Care organization & administration, Disease Susceptibility, Drug Interactions, Humans, Immunosuppression Therapy adverse effects, Italy epidemiology, Liver Cirrhosis, Alcoholic epidemiology, Liver Cirrhosis, Alcoholic therapy, Liver Transplantation, Recurrence, SARS-CoV-2, Societies, Medical, Telemedicine, COVID-19 Drug Treatment, Alcoholism therapy, COVID-19 prevention & control, Communicable Disease Control
- Abstract
Coronavirus disease 2019 (COVID-19) first emerged in China in November 2019. Most governments have responded to the COVID-19 pandemic by imposing a lockdown. Some evidence suggests that a period of isolation might have led to a spike in alcohol misuse, and in the case of patients with alcohol use disorder (AUD), social isolation can favour lapse and relapse. The aim of our position paper is to provide specialists in the alcohol addiction field, in psychopharmacology, gastroenterology and in internal medicine, with appropriate tools to better manage patients with AUD and COVID-19,considering some important topics: (a) the susceptibility of AUD patients to infection; (b) the pharmacological interaction between medications used to treat AUD and to treat COVID-19; (c) the reorganization of the Centre for Alcohol Addiction Treatment for the management of AUD patients in the COVID-19 era (group activities, telemedicine, outpatients treatment, alcohol-related liver disease and liver transplantation, collecting samples); (d) AUD and SARS-CoV-2 vaccination. Telemedicine/telehealth will undoubtedly be useful/practical tools even though it remains at an elementary level; the contribution of the family and of caregivers in the management of AUD patients will play a significant role; the multidisciplinary intervention involving experts in the treatment of AUD with specialists in the treatment of COVID-19 disease will need implementation. Thus, the COVID-19 pandemic is rapidly leading addiction specialists towards a new governance scenario of AUD, which necessarily needs an in-depth reconsideration, focusing attention on a safe approach in combination with the efficacy of treatment., (© 2021 The Authors. Addiction Biology published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction.)
- Published
- 2022
- Full Text
- View/download PDF
118. Life cycle assessment of the food waste management with a focus on the collection bag.
- Author
-
Dolci, Giovanni, Rigamonti, Lucia, and Grosso, Mario
- Subjects
FOOD waste ,WASTE management ,FOOD industrial waste ,ANAEROBIC digestion ,WASTE treatment ,PAPER bags ,BAGGAGE handling in airports ,LUGGAGE - Abstract
The organic fraction (mainly food waste) is typically the most abundant of the separately collected waste streams. The research aims at investigating the influence of different types of collection bag on the environmental performances of the food waste management chain in Italy. A comparative life cycle assessment (LCA) between two alternative systems based on paper or bioplastic collection bags was carried out. It included the collection bags manufacturing and distribution, their use at the household, the transportation of collected food waste and its subsequent anaerobic digestion, including the valorisation of useful outputs and the management of residues. The two systems were modelled mainly with primary data related to the current management system and to tests performed on bags. The LCA was performed with two different modelling approaches applied in the environmental product declaration (EPD) system and in the product environmental footprint (PEF) studies, respectively. In the scenario representing the average conditions, higher environmental impacts are shown by the use of bioplastic bags compared to paper ones with the EPD approach (+257%/+576%). With the PEF approach, the differences between the two systems are lower (−55%/+133%). Moreover, paper bags could allow for further impact reductions assuming a decrease of the food waste collection frequency, allowed by higher weight losses and a lower generation of leachate and odour during the household storage. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
119. Transradial approach for carotid artery stenting: A position paper from the Italian Society of Interventional Cardiology (SICI-GISE).
- Author
-
Montorsi P, Cortese B, Cernetti C, Lanzellotti D, Di Palma G, Marchese A, and Cremonesi A
- Subjects
- Carotid Arteries, Humans, Italy, Radial Artery diagnostic imaging, Radial Artery surgery, Treatment Outcome, Cardiology, Stents
- Abstract
Carotid artery stenting (CAS) is a valid and effective alternative to endoatherectomy when performed by experienced operators. The conventional approach used is the transfemoral one, but in the last 10 years a transradial (TR) approach, the standard access for cardiac catheterization, became widely adopted for peripheral vascular interventions, included the extracranial carotids. Preliminary experiences suggest this approach as safe and effective, especially in specific anatomical and clinical settings that have been shown to be associated with high risk of complications from the femoral route. Lacking international guidelines, this document, promoted by the Italian Society of Interventional Cardiology - Gruppo Italiano Studi Emodinamici (SICI-GISE), was drawn-up by a panel of interventional cardiologists with a documented experience on the subject, focusing on the indications, techniques and materials that should be used for this type of intervention and the most recent literature on the subject., (© 2021 Wiley Periodicals LLC.)
- Published
- 2021
- Full Text
- View/download PDF
120. The respiratory metabolism of overwintering paper wasp gynes (Polistes dominula and Polistes gallicus).
- Author
-
Kovac, Helmut, Käfer, Helmut, Petrocelli, Iacopo, and Stabentheiner, Anton
- Subjects
- *
MEDITERRANEAN climate , *WASPS , *TEMPERATE climate , *METABOLISM , *ENERGY conservation , *WINTER - Abstract
Winter in climatic regions with low temperatures is a challenge for overwintering insects. They are exposed to temperature extremes, which directly cause mortality or lead to energy depletion. The winter hibernaculum of paper wasp gynes protects from predators and rain, but only poorly from ambient temperature. In order to detect physiological adaptations to differing climates, we compared the respiratory metabolism of overwintering gynes of two polistine species from the Mediterranean climate in Italy (Polistes dominula and Polistes gallicus), and of one species from the temperate climate in Austria (Polistes dominula). The wasps' CO2 emission was measured with stop‐flow respirometry in a temperature range from 2.5 to 20 °C. The mass‐specific standard (resting) metabolic rate, the main type of metabolism of the dormant insects during overwintering, increased exponentially with ambient temperature but was suppressed in comparison to individuals measured in the summer, which conserves the energy stores. In addition, it was lower in the Mediterranean species (P. dominula and P. gallicus) in comparison to the temperate species (P. dominula), especially at higher temperatures. The active metabolic rate was suppressed to a similar amount. The suppressed metabolism of the overwintering Mediterranean gynes could be an adaptation to the higher winter temperatures to prevent a premature depletion of the energy resources. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
121. The Italian law on body donation: A position paper of the Italian College of Anatomists.
- Author
-
De Caro R, Boscolo-Berto R, Artico M, Bertelli E, Cannas M, Cappello F, Carpino G, Castorina S, Cataldi A, Cavaletti GA, Cinti S, Cocco LI, Cremona O, Crivellato E, De Luca A, Falconi M, Familiari G, Ferri GL, Fornai F, Gesi M, Geuna S, Gibelli DM, Giordano A, Gobbi P, Guerra G, Gulisano M, Macchi V, Macchiarelli G, Manzoli L, Michetti F, Miscia S, Montagnani S, Montella ACM, Morini S, Onori P, Palumbo C, Papa M, Porzionato A, Quacci DE, Raspanti M, Rende M, Rezzani R, Ribatti D, Ripani M, Rodella LF, Rossi P, Sbarbati A, Secchiero P, Sforza C, Stecco C, Toni R, Vercelli A, Vitale M, Zancanaro C, Zauli G, Zecchi S, Anastasi GP, and Gaudio E
- Subjects
- Cadaver, Humans, Italy, Tissue Donors, Anatomists, Students, Medical, Tissue and Organ Procurement
- Abstract
In Italy, recent legislation (Law No. 10/2020) has tuned regulations concerning the donation of one's postmortem body and tissues for study, training, and scientific research purposes. This study discusses several specific issues to optimise the applicability and effectiveness of such an important, novel regulatory setting. Critical issues arise concerning the learners, the type of training and teaching activities that can be planned, the position of academic anatomy institutes, the role of family members in the donation process, the time frame of the donation process, the eligibility of partial donation, or the simultaneous donation of organs and tissues to patients awaiting transplantation. In particular, a universal time limit for donations (i.e., one year) makes it impossible to plan the long-term use of specific body parts, which could be effectively preserved for the advanced teaching and training of medical students and surgeons. The abovementioned conditions lead to the limited use of corpses, thus resulting in the inefficiency of the whole system of body donation. Overall, the donors' scope for the donation of their body could be best honoured by a more flexible and tuneable approach that can be used on a case-by-case basis. Furthermore, it is deemed necessary to closely monitor the events scheduled for corpses in public nonacademic institutions or private enterprises. This paper presents useful insights from Italian anatomists with the hope of providing inspiration for drafting the regulations. In conclusion, this paper focuses on the critical issues derived from the recently introduced Italian law on the donation and use of the body after death and provides suggestions to lawmakers for future implementations., (Copyright © 2021 Elsevier GmbH. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
122. Adult Pulmonary Intensive and Intermediate Care Units: The Italian Thoracic Society (ITS-AIPO) Position Paper.
- Author
-
Renda, Teresa, Scala, Raffaele, Corrado, Antonio, Ambrosino, Nicolino, and Vaghi, Adriano
- Subjects
- *
HOSPITAL respiratory services , *PULMONOLOGISTS , *RESPIRATORY insufficiency , *PROFESSIONS , *HEALTH services administration , *RESPIRATORY therapy equipment , *MATHEMATICAL models , *REGULATORY approval , *SUBACUTE care , *MEDICAL care use , *RESPIRATORY therapy , *CRITICAL care medicine , *HOSPITAL wards , *QUALITY assurance , *THEORY , *ADULTS - Abstract
The imbalance between the prevalence of patients with acute respiratory failure (ARF) and acute-on-chronic respiratory failure and the number of intensive care unit (ICU) beds requires new solutions. The increasing use of non-invasive respiratory tools to support patients at earlier stages of ARF and the increased expertise of non-ICU clinicians in other types of supportive care have led to the development of adult pulmonary intensive care units (PICUs) and pulmonary intermediate care units (PIMCUs). As in other European countries, Italian PICUs and PIMCUs provide an intermediate level of care as the setting designed for managing ARF patients without severe non-pulmonary dysfunction. The PICUs and PIMCUs may also act as step-down units for weaning patients from prolonged mechanical ventilation and for discharging patients still requiring ventilatory support at home. These units may play an important role in the on-going coronavirus disease 2019 pandemic. This position paper promoted by the Italian Thoracic Society (ITS-AIPO) describes the models, facilities, staff, equipment, and operating methods of PICUs and PIMCUs. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
123. From Paper to Film: Historical and Cultural Implications of Italian Illustrated Editions of Little Women (1908-1945).
- Author
-
Abbatelli, Valentina
- Subjects
HISTORICAL films ,IMAGE analysis ,HISTORY of publishing ,ITALIAN films ,ILLUSTRATED books ,ITALIAN history ,ITALIAN literature - Abstract
This article analyses Italian illustrated editions of Little Women published between 1908 and 1945. After an overview of the publishing history of the novel in Italy, the paper will examine Italian illustrations as hermeneutic tools in order to examine their ideological function in the representation of gender. The belated reception of Alcott's novel in Italy, caused by its representation of a nonconformist educational model for girls, is mirrored in the tension between the nationalistic drive and the influence of foreign models that can be pinpointed in the illustrated editions. By analyzing adaptations of American illustrations, original Italian creations, and omissions of iconic illustrations, this paper will unveil how much the visual element is embedded in the Italian historical and cultural context, as the choice (or omission) of particular images impacted the interpretation of the book. By examining the Italian editions of Little Women published in this time frame, we will also be able to retrace the links with the American illustrated history of the book and bear testimony to the powerful impact of the 1934 film version on printed editions. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
124. Capitalism and Communications: The Rise of Commercial Courier Networks in the Context of the Champagne Fairs.
- Author
-
Kittler, Juraj
- Subjects
BANKING industry ,CAPITALISM ,BUSINESS development ,PAPER industry - Abstract
This essay examines the nexus between the roots of modern capitalism and the rise of the first networks of pedestrian couriers known as scarsella , arguing that they both emerged simultaneously during the thirteenth century in the context of the Champagne fairs. This claim is based upon the premise that the essential feature of the commercial revolution of the Middle Ages—the rise of the sedentary merchant—would have been literally unthinkable without the establishment of reliable communication channels and the mastering of paper manufacturing in northern Italy. Paper represented a light and affordable medium that revolutionized business by enabling merchants to carry out not only long-distance communication but also extensive record-keeping. However, this study proposes that the earliest public postal operations in Europe were driven not by merchants' desire to conduct epistolary exchange but by the need of the commercial banks to execute long-distance money transfers through bills of exchange. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
125. The tumor-agnostic treatment for patients with solid tumors: a position paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIF Italian Scientific Societies.
- Author
-
Russo A, Incorvaia L, Malapelle U, Del Re M, Capoluongo E, Vincenzi B, Chiari R, Cortesi L, Danesi R, Florena AM, Fontanini G, Gori S, Marchetti A, Normanno N, Pinto C, Sangiolo D, Silvestris N, Tagliaferri P, Tallini G, Cinieri S, and Beretta GD
- Subjects
- Humans, Italy, Medical Oncology, Precision Medicine, Neoplasms drug therapy, Neoplasms genetics, Societies, Scientific
- Abstract
The personalized medicine is in a rapidly evolving scenario. The identification of actionable mutations is revolutionizing the therapeutic landscape of tumors. The morphological and histological tumor features are enriched by the extensive genomic profiling, and the first tumor-agnostic drugs have been approved regardless of tumor histology, guided by predictive and druggable genetic alterations. This new paradigm of "mutational oncology", presents a great potential to change the oncologic therapeutic scenario, but also some critical aspects need to be underlined. A process governance is mandatory to ensure the genomic testing accuracy and homogeneity, the economic sustainability, and the regulatory issues, ultimately granting the possibility of translating this model in the "real world". In this position paper, based on experts' opinion, the AIOM-SIAPEC-IAP-SIBIOC-SIF Italian Scientific Societies revised the new agnostic biomarkers, the diagnostic technologies available, the current availability of agnostic drugs and their present indication., (Copyright © 2021. Published by Elsevier B.V.)
- Published
- 2021
- Full Text
- View/download PDF
126. Selection of antiseizure medications for first add-on use: A consensus paper.
- Author
-
Gambardella A, Tinuper P, Acone B, Bonanni P, Coppola G, and Perucca E
- Subjects
- Adult, Child, Consensus, Humans, Italy, Epilepsy drug therapy
- Abstract
Introduction: When monotherapy used alone or sequentially fails to achieve seizure control, a trial of combination therapy may be considered., Objective: To define optimal criteria to guide choice of an antiseizure medication (ASM) for use as first add-on., Methods: A standardized Delphi procedure was applied to produce a list of consensus statements. First, an Expert Board consisting of 5 epileptologists agreed on a set of 46 statements relevant to the objective. The statements were then finalized through an iterative process by a Delphi Panel of 84 Italian pediatric and adult neurologists with expertise in the management of epilepsy. Panel members provided anonymous ratings of their level of agreement with each statement on a 9-point Likert scale., Results: Consensus, defined as agreement by at least 80% of Panel members, was reached for 36 statements. Medication-related factors considered to be important for drug selection included efficacy, tolerability and safety, interaction potential, mechanism of action, and ease of use. The need to optimize adherence and to tailor drug selection to individual characteristics was emphasized., Conclusions: Choice of an ASM for first add-on requires consideration of many factors, many of which also apply to choose initial treatment. Factors more specifically relevant to add-on use include drug interaction potential and the preference for an ASM with a different mechanism of action., Competing Interests: Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Antonio Gambardella received speaker’s or consultancy fees from Eisai, UCB Pharma and Zogenix. Paolo Tinuper received speaker’s or consultancy fees from Arvelle, Eisai, GW Pharma, LivaNova, UCB Pharma, Xenon Pharma and Zogenix. Benedetto Acone received speaker’s or consultancy fees for projects sponsored by Eisai, Astra Zeneca, Novartis, Gilead, Abbvie, Sanofi, Sandoz, Sobi, MSD, Angelini, AlfaSigma, Janssen, Kyowa Kirin, Abiogen, Amgen, Teva; Giangennaro Coppola received speaker’s or consultant fees from Eisai and Humana; Paolo Bonanni received speaker’s or consultancy fees from Eisai, LivaNova, Lusofarmaco and Proveca; Emiio Perucca received speaker’s or consultancy fees from Arvelle, Biogen, Corlieve, Eisai, GW Pharma, Sanofi, Sun Pharma, UCB Pharma, Xenon Pharma and Zogenix., (Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
127. Dosimetric optimization of nuclear medicine therapy based on the Council Directive 2013/59/EURATOM and the Italian law N. 101/2020. Position paper and recommendations by the Italian National Associations of Medical Physics (AIFM) and Nuclear Medicine (AIMN).
- Author
-
Chiesa C, Strigari L, Pacilio M, Richetta E, Cannatà V, Stasi M, Marzola MC, Schillaci O, Bagni O, and Maccauro M
- Subjects
- European Union, Humans, Italy, Physics, Radiometry, Nuclear Medicine
- Abstract
This recommendation by the Italian Associations of Nuclear Medicine (AIMN) and Medical Physics (AIFM) focuses on the dosimetric optimization of Nuclear Medicine Therapy (NMT) as clearly requested by the article 56 of the EURATOM Directive 2013/59 and its consequent implementation in article 158 in the Italian Law n. 101/2020. However, this statement must deal with scientific and methodological limits that still exist and, above all, with the currently available limited resources. This paper addresses these specific issues. It distinguishes among many possible kinds of NMT. For each type, dosimetric optimization is recommended or considered optional, according to the general criteria adopted in any human choice, i.e. a check of technical feasibility first, followed by a cost/benefit argument. The classification of therapies as standardized or non-standardized is presented. This is based on the complexity of the type of pathology, on the variability of the treatment outcome, and on the risks involved. According to the present document, which was officially delivered to Italian Health Ministry as necessary interpretation of the law, a therapeutic team can, in science and consciousness, overcome the indications of posology, to optimize and tailoring a treatment with dosimetry, on the basis of published national or international data or guidelines, without need of an Ethics Committee approval. Data collected in this way will provide additional evidence about optimal dosimetric reference values. As conclusion, a formal appeal is made to the European and National regulatory agencies for pharmaceuticals to obtain the official acknowledgment of this principle., (Copyright © 2021 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
128. Critical concepts and management recommendations for cutaneous T-cell lymphoma: A consensus-based position paper from the Italian Group of Cutaneous Lymphoma.
- Author
-
Zinzani PL, Quaglino P, Violetti SA, Cantonetti M, Goteri G, Onida F, Paulli M, Rupoli S, Barosi G, and Pimpinelli N
- Subjects
- Adult, Biomarkers, Tumor genetics, Female, Humans, Italy, Consensus, Lymphoma, T-Cell, Cutaneous diagnosis, Lymphoma, T-Cell, Cutaneous genetics, Lymphoma, T-Cell, Cutaneous therapy
- Abstract
In this paper, we present a review of critical concepts, and produce recommendations on management issues in cutaneous T-cell lymphomas (CTCLs) of adults. A panel of nine experts was selected for their expertise in research and clinical practice of CTCLs. During an initial meeting, the areas of major concern in the management of CTCLs were selected by generating and rank-ordering clinical key questions using the criterion of clinical relevance, through group discussion. Recommendations were achieved by multiple-step formalized procedures to reach a consensus after a comprehensive analysis of the scientific literature. The panel produced recommendations on how to facilitate the clinical suspicion of CTCL; indication of cutaneous biopsy; optimal histological diagnosis, immunohistochemistry and genetic markers; and staging pathway and up-to-date therapeutics (with particular focus on new treatments). The critical concept of integration of the different medical expertise in the management of the patients with CTCL was thoroughly examined. These recommendations are intended for use not only by expert centers but above all by "not experienced" dermatologists and hematologists as well as general practitioners., (© 2020 John Wiley & Sons Ltd.)
- Published
- 2021
- Full Text
- View/download PDF
129. Position paper on the use of COVID-19 convalescent plasma: an update.
- Author
-
Prati D, Fiorin F, Berti P, De Silvestro G, Accorsi P, and Ostuni A
- Subjects
- COVID-19 blood, Humans, Immunization, Passive standards, Inpatients, Italy, Meta-Analysis as Topic, Randomized Controlled Trials as Topic, Treatment Outcome, COVID-19 Serotherapy, COVID-19 therapy, Consensus
- Published
- 2021
- Full Text
- View/download PDF
130. AES 144TH CONVENTION PAPER AND E-BRIEF ABSTRACTS.
- Subjects
ELECTROSTATIC loudspeakers - Published
- 2018
131. Abstract-to-publication ratio and predictors for publication success for papers presented at the Italian Emergency Medicine Meeting: an updated cross-sectional study.
- Author
-
Menditto VG, Montillo L, Raponi A, and Barbadoro P
- Subjects
- Cross-Sectional Studies, Humans, Italy, Publishing, Societies, Medical, Emergency Medicine
- Published
- 2020
- Full Text
- View/download PDF
132. Position paper on liver and kidney diseases from the Italian Association for the Study of Liver (AISF), in collaboration with the Italian Society of Nephrology (SIN).
- Author
-
Morelli MC, Rendina M, La Manna G, Alessandria C, Pasulo L, Lenci I, Bhoori S, Messa P, Biancone L, Gesualdo L, Russo FP, Petta S, and Burra P
- Subjects
- Gastroenterology, Humans, Italy, Nephrology, Societies, Medical, Liver Diseases complications, Renal Insufficiency, Chronic complications
- Abstract
Liver and kidney are strictly connected in a reciprocal manner, in both the physiological and pathological condition. The Italian Association for the Study of Liver, in collaboration with the Italian Society of Nephrology, with this position paper aims to provide an up-to-date overview on the principal relationships between these two important organs. A panel of well-recognized international expert hepatologists and nephrologists identified five relevant topics: 1) The diagnosis of kidney damage in patients with chronic liver disease; 2) Acute kidney injury in liver cirrhosis; 3) Association between chronic liver disease and chronic kidney disease; 4) Kidney damage according to different etiology of liver disease; 5) Polycystic kidney and liver disease. The discussion process started with a review of the literature relating to each of the five major topics and clinical questions and related statements were subsequently formulated. The quality of evidence and strength of recommendations were graded according to the GRADE system. The statements presented here highlight the importance of strong collaboration between hepatologists and nephrologists for the management of critically ill patients, such as those with combined liver and kidney impairment., Competing Interests: Declaration of Competing Interest Maria Cristina Morelli: has served on advisory boards for Abbvie, Gilead sciences, Shionogi srl. Carlo Alessandria: reports personal fees from Alfasigma, outside the submitted work. Sherrie Bhoori: has served as speaker bureau for Boston Scientific, Eisai, Ipsen, Kedrion. Salvatore Petta: has served as Advisor and/or Speaker for AbbVie, Gilead, Intercept and Pfyze.r Patrizia Burra: has served as Advisor and/or Speaker for Kedrion, Biotest and Chiesi Farmaceutici. Maria Rendina, Ilaria Lenci, Piergiorgio Messa, Loreto Gesualdo, Francesco Paolo Russo Luisa Pasulo, Gaetano La Manna, Luigi Biancone: none to disclose., (Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
133. The molecular profiling of solid tumors by liquid biopsy: a position paper of the AIOM-SIAPEC-IAP-SIBioC-SIC-SIF Italian Scientific Societies.
- Author
-
Russo A, Incorvaia L, Del Re M, Malapelle U, Capoluongo E, Gristina V, Castiglia M, Danesi R, Fassan M, Giuffrè G, Gori S, Marchetti A, Normanno N, Pinto C, Rossi G, Santini D, Sartore-Bianchi A, Silvestris N, Tagliaferri P, Troncone G, Cinieri S, and Beretta GD
- Subjects
- Biomarkers, Tumor genetics, Humans, Italy, Liquid Biopsy, Neoplastic Cells, Circulating, Societies, Scientific
- Abstract
The term liquid biopsy (LB) refers to the use of various biological fluids as a surrogate for neoplastic tissue to achieve information for diagnostic, prognostic and predictive purposes. In the current clinical practice, LB is used for the identification of driver mutations in circulating tumor DNA derived from both tumor tissue and circulating neoplastic cells. As suggested by a growing body of evidence, however, there are several clinical settings where biological samples other than tissue could be used in the routine practice to identify potentially predictive biomarkers of either response or resistance to targeted treatments. New applications are emerging as useful clinical tools, and other blood derivatives, such as circulating tumor cells, circulating tumor RNA, microRNAs, platelets, extracellular vesicles, as well as other biofluids such as urine and cerebrospinal fluid, may be adopted in the near future. Despite the evident advantages compared with tissue biopsy, LB still presents some limitations due to both biological and technological issues. In this context, the absence of harmonized procedures corresponds to an unmet clinical need, ultimately affecting the rapid implementation of LB in clinical practice. In this position paper, based on experts' opinions, the AIOM-SIAPEC-IAP-SIBIOC-SIF Italian Scientific Societies critically discuss the most relevant technical issues of LB, the current and emerging evidences, with the aim to optimizing the applications of LB in the clinical setting., Competing Interests: Disclosure GB: Consulting fees: Lilly, Eisai, Incyte, Servier; honoraria for presentations: Clovis Oncology, Merck; support for attending meetings: Roche, Ipsen, Celgene, Servier, Sanofi; advisory board: Eisai. MF: Grants: QED Therapeutics, Astellas Pharma; consulting fees: Diaceutics, Tesaro-GSK, Astellas Pharma. UM: Personal fees from Boehringer Ingelheim, AstraZeneca, Roche, Merck Sharp & Dohme (MSD), Amgen, Merck, Eli Lilly, Thermo Fisher, Diaceutics for participation in a speaker bureau or for acting in an advisory role, outside the submitted work. NN: Grants: Merck, Sysmex, Thermo Fisher, QIAGEN, Roche, AstraZeneca, Biocartis, Illumina; honoraria for presentations: MSD, QIAGEN, Bayer, Biocartis, Illumina, Incyte, Roche, Bristol-Myers Squibb, Merck, Thermo Fisher, Boehringer Ingelheim, AstraZeneca, Sanofi, Eli Lilly; Other financial or non-financial interests: President, International Quality Network for Pathology (IQN Path); President, Italian Cancer Society (SIC). NS: Honoraria for presentations: MSD, Roche, Isheo, Iquvia. GR: honoraria for presentations: Pfizer, Novartis; advisory boards: Eli Lilly, Amgen, MSD. AR: Honorarium for advisory boards: Bristol, Pfizer, Bayer, Kyowa Kirin, Ambrosetti; Speaker honorarium: Roche Diagnostic. AS-B: Advisory Board: Amgen, Bayer, Sanofi, Servier, MSD. All other authors have declared no conflicts of interest., (Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
134. Commentary to the paper: A child of two mothers: what about the father? Italian overview.
- Author
-
Di Luca A
- Subjects
- Child, Female, Humans, Italy, Male, Parents, Reproductive Techniques, Assisted, Fathers, Mothers
- Abstract
Assisted reproductive techniques have made it possible for same-sex couples to become "parents", and for children to have two mothers, or even two fathers. Such parents have applied for the legal registration of the birth certificates issued abroad for children born through assisted procreation procedures that would not have been legally possible in Italy. The Italian Constitutional Court and the Supreme Court of Cassation have however ruled against such recognition, pointing out that the children's best interest can be pursued through adoption "in extraordinary circumstances", as regulated by law n. 184, enacted in 1983. The article's Author has stressed the need for new piece of legislation, specifically aimed at more effectively regulating such scenarios. We share that sentiment, and wholeheartedly hope that Italian lawmakers will soon draw up and enact a new law, based on adoption in exceptional circumstances, so that children born abroad through assisted reproduction may be allowed to live in a loving family settings, raised by the parents who made their births possible in the first place. Such new norms will have to ensure that the children's well-being and fundamental rights are upheld, including the right to know their biological origins.
- Published
- 2021
- Full Text
- View/download PDF
135. Diagnostic Approach to Acute Liver Failure in Children: A Position Paper by the SIGENP Liver Disease Working Group.
- Author
-
Di Giorgio A, Bartolini E, Calvo PL, Cananzi M, Cirillo F, Della Corte C, Dionisi-Vici C, Indolfi G, Iorio R, Maggiore G, Mandato C, Nebbia G, Nicastro E, Pinon M, Ranucci G, Sciveres M, Vajro P, and D'Antiga L
- Subjects
- Acetaminophen adverse effects, Child, Child, Preschool, Humans, Infant, Infant, Newborn, Italy, Liver Failure, Acute blood, Liver Failure, Acute etiology, Liver Failure, Acute therapy, Liver Failure, Acute diagnosis
- Abstract
Acute liver failure (ALF) is a clinical condition characterized by the abrupt onset of coagulopathy and biochemical evidence of hepatocellular injury, leading to rapid deterioration of liver cell function. In children, ALF has been characterized by raised transaminases, coagulopathy, and no known evidence of pre-existing chronic liver disease; unlike in adults, the presence of hepatic encephalopathy is not required to establish the diagnosis. Although rare, ALF has a high mortality rate without liver transplantation (LT). Etiology of ALF varies with age and geographical location, although it may remain indeterminate in a significant proportion of cases. However, identifying its etiology is crucial to undertake disease-specific management and evaluate indication to LT. In this position statement, the Liver Disease Working Group of the Italian Society of Gastroenterology, Hepatology and Nutrition (SIGENP) reviewed the most relevant studies on pediatric ALF to provide recommendations on etiology, clinical features and diagnostic work-up of neonates, infants and children presenting with ALF. Recommendations on medical management and transplant candidacy will be discussed in a following consensus conference., (Copyright © 2021 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
136. Intertrade Hellas S.A. Chooses A. Celli Paper for its New Tissue Production Line.
- Subjects
- *
TISSUE paper , *TISSUE paper industry , *TISSUE paper manufacturing - Published
- 2022
137. Gastroprotection in patients on antiplatelet and/or anticoagulant therapy: a position paper of National Association of Hospital Cardiologists (ANMCO) and the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO).
- Author
-
Abrignani MG, Gatta L, Gabrielli D, Milazzo G, De Francesco V, De Luca L, Francese M, Imazio M, Riccio E, Rossini R, Scotto di Uccio F, Soncini M, Zullo A, Colivicchi F, Di Lenarda A, Gulizia MM, and Monica F
- Subjects
- Anticoagulants adverse effects, Gastrointestinal Hemorrhage chemically induced, Gastrointestinal Hemorrhage epidemiology, Hospitals, Humans, Italy, Platelet Aggregation Inhibitors adverse effects, Proton Pump Inhibitors therapeutic use, Cardiologists, Gastroenterologists, Helicobacter Infections complications, Helicobacter Infections drug therapy, Helicobacter pylori
- Abstract
Aspirin and P2Y
12 receptor antagonists are widely used across the spectrum of cardiovascular and cerebrovascular diseases. Gastrointestinal complications, including ulcer and bleeding, are relatively common during antiplatelet treatment and, therefore, concomitant proton pump inhibitor (PPI) treatment is often prescribed. However, potential increased risk of cardiovascular events has been suggested for PPIs, and, in recent years, it has been discussed whether these drugs may reduce the cardiovascular protection by aspirin and, even more so, clopidogrel. Indeed, pharmacodynamic and pharmacokinetic studies suggested an interaction through hepatic CYP2C19 between PPIs and clopidogrel, which could translate into clinical inefficacy, leading to higher rates of cardiovascular events. The FDA and the EMA sent a warning in 2010 discouraging the concomitant use of clopidogrel with omeprazole or esomeprazole. In addition, whether the use of PPIs may affect the clinical efficacy of the new P2Y12 receptor antagonists, ticagrelor and prasugrel, remains less known. According to current guidelines, PPIs in combination with antiplatelet treatment are recommended in patients with risk factors for gastrointestinal bleeding, including advanced age, concurrent use of anticoagulants, steroids or non-steroidal anti-inflammatory drugs, and Helicobacter pylori infection. Like vitamin K antagonists (VKAs), DOACs can determine gastrointestinal bleeding. Results from both randomized clinical trials and observational studies suggest that high-dose dabigatran (150 mg bid), rivaroxaban and high-dose edoxaban (60 mg daily) are associated with a higher risk of GI bleeding as compared with apixaban and warfarin. In patients taking oral anticoagulant with GI risk factor, PPI could be recommended, even if usefulness of PPIs in these patients deserves further data. Helicobacter pylori should always be searched, and treated, in patients with history of peptic ulcer disease (with or without complication). Given the large number of patients treated with antithrombotic drugs and PPIs, even a minor reduction of platelet inhibition or anticoagulant effect potentially carries a considerable clinical impact. The present joint statement by ANMCO and AIGO summarizes the current knowledge regarding the widespread use of platelet inhibitors, anticoagulants, and PPIs in combination. Moreover, it outlines evidence supporting or opposing drug interactions between these drugs and discusses consequent clinical implications., (Copyright © 2020. Published by Elsevier B.V.)- Published
- 2021
- Full Text
- View/download PDF
138. Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT).
- Author
-
Mussini C, Falcone M, Nozza S, Sagnelli C, Parrella R, Meschiari M, Petrosillo N, Mastroianni C, Cascio A, Iaria C, Galli M, Chirianni A, Sagnelli E, Iacobello C, Di Perri G, Mazzotta F, Carosi G, Tinelli M, Grossi P, Armignacco O, Portelli V, Andreoni M, and Tavio M
- Subjects
- COVID-19 diagnosis, COVID-19 epidemiology, COVID-19 therapy, Humans, Italy epidemiology, Randomized Controlled Trials as Topic, SARS-CoV-2 isolation & purification, Standard of Care, Practice Guidelines as Topic, Societies, Medical standards, COVID-19 Drug Treatment
- Abstract
Scope: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has become pandemic, reaching almost one million death worldwide. At present standard treatment for coronavirus disease 2019 (COVID-19) is not well defined because the evidence, either from randomized or observational studies, with conflicting results, has led to rapid changes in treatment guidelines. Our aim was to narratively summarize the available literature on the management of COVID-19 in order to combine current evidence and interpretation of the data by experts who are treating patients in the frontline setting., Methods: The panel conducted a detailed review of the literature and eventual press releases from randomized clinical trials for each possible available treatment. Inductive PubMed search waws performed for publications relevant to the topic, including all clinical trials conducted. The result was a flowchart with treatment indications for patients with COVID-19., Implications: After 6 months of a pandemic situation and before a possible second coronavirus wave descends on Europe, it is important to evaluate which drugs proved to be effective while also considering that results from many randomized clinical trials are still awaited. Indeed, among treatments for COVID-19, only glucocorticoids have resulted in an association with a significant decrease in mortality in published randomized controlled trials. New therapeutic strategies are urgently needed., (Copyright © 2020. Published by Elsevier Ltd.)
- Published
- 2021
- Full Text
- View/download PDF
139. Prehospital Emergency Medical Services: Paper Versus Technology.
- Author
-
Piani T, Boccolato L, Ruzza G, Pausler D, Trillò G, Macor C, Pascolo P, and De Monte A
- Subjects
- Documentation, Humans, Italy, Technology, Emergency Medical Services
- Abstract
Digital technology has an essential role in the development and application of innovations within the health care system. Its application is not limited to the hospital environment but extends to the emergency medical services system. The experimental phase of the shift to electronic emergency medical services documentation was performed within the Azienda Sanitaria Universitaria Friuli Centrale of Udine (Italy), a local health authority covering about 533 000 inhabitants. Considering the results of this study, we believe it is important to continue to update the methods of data collection and analysis in correlation with the management and outcomes of the patients., (Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
140. Management of perforated diverticulitis with generalized peritonitis. A multidisciplinary review and position paper.
- Author
-
Nascimbeni R, Amato A, Cirocchi R, Serventi A, Laghi A, Bellini M, Tellan G, Zago M, Scarpignato C, and Binda GA
- Subjects
- Anastomosis, Surgical, Colostomy, Humans, Italy, Diverticulitis surgery, Diverticulitis, Colonic surgery, Intestinal Perforation etiology, Intestinal Perforation surgery, Laparoscopy, Peritonitis complications, Peritonitis surgery
- Abstract
Perforated diverticulitis is an emergent clinical condition and its management is challenging and still debated. The aim of this position paper was to critically review the available evidence on the management of perforated diverticulitis and generalized peritonitis in order to provide evidence-based suggestions for a management strategy. Four Italian scientific societies (SICCR, SICUT, SIRM, AIGO), selected experts who identified 5 clinically relevant topics in the management of perforated diverticulitis with generalized peritonitis that would benefit from a multidisciplinary review. The following 5 issues were tackled: 1) Criteria to decide between conservative and surgical treatment in case of perforated diverticulitis with peritonitis; 2) Criteria or scoring system to choose the most appropriate surgical option when diffuse peritonitis is confirmed 3); The appropriate surgical procedure in hemodynamically stable or stabilized patients with diffuse peritonitis; 4) The appropriate surgical procedure for patients with generalized peritonitis and septic shock and 5) Optimal medical therapy in patients with generalized peritonitis from diverticular perforation before and after surgery. In perforated diverticulitis surgery is indicated in case of diffuse peritonitis or failure of conservative management and the decision to operate is not based on the presence of extraluminal air. If diffuse peritonitis is confirmed the choice of surgical technique is based on intraoperative findings and the presence or risk of severe septic shock. Further prognostic factors to consider are physiological derangement, age, comorbidities, and immune status. In hemodynamically stable patients, emergency laparoscopy has benefits over open surgery. Options include resection and anastomosis, Hartmann's procedure or laparoscopic lavage. In generalized peritonitis with septic shock, an open surgical approach is preferred. Non-restorative resection and/or damage control surgery appear to be the only viable options, depending on the severity of hemodynamic instability. Multidisciplinary medical management should be applied with the main aims of controlling infection, relieving postoperative pain and preventing and/or treating postoperative ileus. In conclusion, the complexity and diversity of patients with diverticular perforation and diffuse peritonitis requires a personalized strategy, involving a thorough classification of physiological derangement, staging of intra-abdominal infection and choice of the most appropriate surgical procedure.
- Published
- 2021
- Full Text
- View/download PDF
141. Management of paediatric IBD after the peak of COVID-19 pandemic in Italy: A position paper on behalf of the SIGENP IBD working group.
- Author
-
Arrigo S, Alvisi P, Banzato C, Bramuzzo M, Civitelli F, Corsello A, D'Arcangelo G, Dilillo A, Dipasquale V, Felici E, Fuoti M, Gatti S, Giusti Z, Knafelz D, Lionetti P, Mario F, Marseglia A, Martelossi S, Moretti C, Norsa L, Nuti F, Panceri R, Rampado S, Renzo S, Romano C, Romeo E, Strisciuglio C, and Martinelli M
- Subjects
- Child, Humans, Italy, Organizational Innovation, Risk Adjustment, SARS-CoV-2, COVID-19 epidemiology, COVID-19 prevention & control, Communicable Disease Control methods, Gastroenterology methods, Gastroenterology organization & administration, Gastroenterology trends, Inflammatory Bowel Diseases epidemiology, Inflammatory Bowel Diseases therapy, Pediatrics methods, Pediatrics organization & administration, Pediatrics trends
- Abstract
Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2, spreading in Italy during the first months of 2020, abruptly changed the way of practicing medicine in this country. As a consequence of the lockdown, the diagnostic and therapeutic management of paediatric chronic conditions, such as inflammatory bowel disease (IBD) has been affected. During the peak of COVID-19 pandemic, elective visits, endoscopies and infusions have been postponed, with potential clinical and psychological impact on disease course and a high likelihood of increasing waiting lists. While slowly moving back towards normality, clinicians need to recognize the best ways to care for patients with IBD, carefully avoiding risk factors for new potential epidemic outbreaks. In this uncertain scenario until the development and spread of COVID-19 vaccine, it is necessary to continue to operate with caution. Hereby we provide useful indications for a safer and gradual restarting of routine clinical activities after COVID-19 peak in Italy., Competing Interests: Declaration of Competing Interest The authors have no conflict of interest to declare., (Copyright © 2020 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
142. Heparin induced thrombocytopenia: position paper from the Italian Society on Thrombosis and Haemostasis (SISET).
- Author
-
Marcucci R, Berteotti M, Gori AM, Giusti B, Rogolino AA, Sticchi E, Liotta AA, Ageno W, De Candia E, Gresele P, Marchetti M, Marietta M, and Tripodi A
- Subjects
- Disease Management, Humans, Italy, Societies, Medical, Thrombocytopenia diagnosis, Thrombocytopenia physiopathology, Anticoagulants adverse effects, Heparin adverse effects, Thrombocytopenia chemically induced, Thrombocytopenia therapy
- Abstract
Heparin induced thrombocytopenia (HIT) is a rare immune mediated adverse drug reaction occurring after exposure to heparin. It is a serious and potentially fatal condition, which may be associated with the development of arterial or venous thrombotic events. Although known for many years, HIT is still often misdiagnosed. Pre- test clinical probability, screening for anti-PF4/heparin antibodies and documentation of their platelet activating capacity are the cornerstones of diagnosis. However, both clinical algorithms and test modalities have limited predictive values and limited diffusion so that the diagnosis and management is challenging in the clinical practice. For this reason, there is an unmet need for novel rational non-anticoagulant therapies based on the pathogenesis of HIT.The present paper reports the position of the Italian Society on Haemostasis and Thrombosis (SISET) in order to increase awareness of HIT among clinicians and other health care professionals and to provide information on the most appropriate management.
- Published
- 2021
- Full Text
- View/download PDF
143. AISF-SIMTI position paper on the appropriate use of albumin in patients with liver cirrhosis: a 2020 update.
- Author
-
Caraceni P, Angeli P, Prati D, Bernardi M, Berti P, Bennardello F, Fiorin F, and Piccoli P
- Subjects
- Disease Management, Evidence-Based Practice, Humans, Italy epidemiology, Liver Cirrhosis blood, Liver Cirrhosis epidemiology, Serum Albumin, Human administration & dosage, Serum Albumin, Human analysis, Liver Cirrhosis therapy, Serum Albumin, Human therapeutic use
- Published
- 2021
- Full Text
- View/download PDF
144. Perceived barriers to the professional development of modern nursing in Italy – A discussion paper.
- Author
-
Bressan, Valentina, Tolotti, Angela, Barisone, Michela, Bagnasco, Annamaria, Sasso, Loredana, Aleo, Giuseppe, and Timmins, Fiona
- Subjects
NURSING practice ,PROFESSIONAL employee training - Abstract
The aim of this paper is to discuss the development of modern nursing in Italy. Specifically, the paper aims to draw attention to the fact that while nursing in Italy has mirrored developments in Europe, in many respects the advancement of the profession is much less accelerated. The paper considers the reasons for this and the contributing factors and explores possible solutions. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
145. Management of status epilepticus in adults. Position paper of the Italian League against Epilepsy.
- Author
-
Minicucci F, Ferlisi M, Brigo F, Mecarelli O, Meletti S, Aguglia U, Michelucci R, Mastrangelo M, Specchio N, Sartori S, and Tinuper P
- Subjects
- Adult, Anticonvulsants therapeutic use, Epilepsy epidemiology, Humans, Italy epidemiology, Neurosurgical Procedures methods, Neurosurgical Procedures standards, Randomized Controlled Trials as Topic methods, Status Epilepticus epidemiology, Disease Management, Epilepsy therapy, Randomized Controlled Trials as Topic standards, Status Epilepticus therapy
- Abstract
Since the publication of the Italian League Against Epilepsy guidelines for the treatment of status epilepticus in 2006, advances in the field have ushered in improvements in the therapeutic arsenal. The present position paper provides neurologists, epileptologists, neurointensive care specialists, and emergency physicians with updated recommendations for the treatment of adult patients with status epilepticus. The aim is to standardize treatment recommendations in the care of this patient population., (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
146. Italian Society of Arterial Hypertension (SIIA) Position Paper on the Role of Renal Denervation in the Management of the Difficult-to-Treat Hypertensive Patient.
- Author
-
Bruno, Rosa Maria, Taddei, Stefano, Borghi, Claudio, Colivicchi, Furio, Desideri, Giovambattista, Grassi, Guido, Mazza, Alberto, Muiesan, Maria Lorenza, Parati, Gianfranco, Pontremoli, Roberto, Trimarco, Bruno, Volpe, Massimo, and Ferri, Claudio
- Subjects
- *
KIDNEY innervation , *DENERVATION , *HYPERTENSION , *PATIENT compliance , *PATIENT safety , *TREATMENT effectiveness , *PATIENT selection , *PATIENTS' attitudes - Abstract
Renal denervation is a device-based procedure for hypertension for which safety and efficacy has been demonstrated. At present, its clinical use is still matter of debate, despite the most recent clinical trials have shown promising results with new-generation devices in various hypertensive populations. This position paper was deemed necessary by the Italian Society of Arterial Hypertension, in order to provide indications about the applications of renal denervation in the clinical setting. A state-of-the art review of the literature, focusing on safety and efficacy data, is provided. Furthermore, based on current evidence and expert consensus, clinical profiles of possible candidates for renal denervation are proposed. The selection process should take into account not only blood pressure values, global cardiovascular risk profile, but also drug adherence and tolerability and patient preferences. This position paper also defines minimum requirements for renal denervation selection centers and a flowchart for the difficult-to-treat hypertensive patient. Further studies are needed to support these preliminary indications, which are based on expert-consensus only. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
147. Oro-Dental Pharmacovigilance in the Digital Age: Promoting Knowledge, Awareness, and Practice in Italy through a Smart Combined System—A Conference at the 30th National Congress of the Italian College of University Professors of Dental Disciplines.
- Author
-
La Mantia, Gaetano, Buttacavoli, Fortunato, Panzarella, Vera, Colella, Giuseppe, Capuano, Annalisa, Sportiello, Liberata, Parrinello, Gaspare, Morreale, Ilaria, Oteri, Giacomo, Bellavia, Giuseppe, Fusco, Vittorio, Mauceri, Rodolfo, Coppini, Martina, Bazzano, Monica, Seminara, Giuseppe, Di Fede, Olga, and Campisi, Giuseppina
- Subjects
DIGITAL technology ,MEDICAL personnel ,DRUG side effects ,UNIVERSITIES & colleges ,ELECTRONIC paper - Abstract
Adverse drug reactions (ADRs) represent a significant threat to patients' safety in dentistry, necessitating proactive measures for prevention and treatment. However, identifying ADRs of dental and oral interest can be challenging, and underreporting remains a persistent issue globally. This paper illustrates a smart system to help Italian healthcare personnel, including dentists, in identifying and reporting dental and oral ADRs. This educational program is within a larger multi-regional project financed by the Italian Agency of Drugs (AIFA). The proposed system comprises a free online questionnaire on ADRs of dental interest (including specific items about awareness and attitudes), and after the free consultation of an atlas of clinical images of dental and oral ADRs linked with a digital synopsis of drugs potentially related to ADRs. This section of the project was presented in April 2023 at the 30th National Congress of the Italian College of University Professors of Dental Disciplines, and the system appears to hold tremendous potential to improve the knowledge of healthcare professionals on oral and dental ADRs. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
148. Paper-and-pencil versus computerized administration mode: Comparison of data quality and risk behavior prevalence estimates in the European school Survey Project on Alcohol and other Drugs (ESPAD).
- Author
-
Colasante, Emanuela, Benedetti, Elisa, Fortunato, Loredana, Scalese, Marco, Potente, Roberta, Cutilli, Arianna, and Molinaro, Sabrina
- Subjects
- *
RISK-taking behavior , *EDUCATIONAL surveys , *CLASSROOM activities , *DATA quality , *TOBACCO use , *BETA lactamases - Abstract
Purpose: The aim of this experimental study was to investigate whether paper-and-pencil and computerized surveys administered in the school setting yield equivalent data quality indicators and risk behavior prevalence estimates. Methods: Data were drawn from the European School Survey Project on Alcohol and Other Drugs (ESPAD®) carried out in Italy to monitor drug, alcohol, tobacco use and other risk-behaviors among Italian high school students aged 15–19 years. A sub-sample of schools was recruited for the study (1673 pupils). For each school, two entire randomly selected courses (from the first to the fifth grade) participated and were assigned randomly to the self-administered paper-and-pencil (N = 811) or computerized survey (N = 862). Differences in data quality were assessed using the following indicators: questionnaire completeness (missing gender and/or 50% of missing answers) and internal consistency (repetitive extreme response patterns). Separate logistic regression models were used to estimate the mode effect on the reporting of each risk behavior, controlling for gender and age. Finally, the prevalence estimates of the experimental study were compared to the results of the national ESPAD® study. Results: The computerized administration mode produced a higher proportion of invalid questionnaires, but the prevalence estimates generated from responses to the paper-and-pencil and computerized surveys were generally equivalent. Nevertheless, comparing these results with those of the national ESPAD® study, some differences in the prevalence rates were found. Conclusions: The findings suggest that in a proctored school setting, the computerized survey mode yields almost the same results as the paper-and-pencil mode. However, because of the reliance on existing informatics facilities until when all schools in the country will be sufficiently equipped for the computerized data collection, they should be given the opportunity to choose between paper-and-pencil and computerized survey modes, in order to avoid a possible selection bias. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
149. Response to the letter by Meng-jun Zhan et al. regarding the paper "A technical report from the Italian SARS-CoV-2 outbreak. Postmortem sampling and autopsy investigation in cases of suspected or probable COVID-19".
- Author
-
Santurro A, Scopetti M, D'Errico S, and Fineschi V
- Subjects
- Autopsy, Betacoronavirus, COVID-19, Humans, Italy epidemiology, SARS-CoV-2, Coronavirus Infections, Disease Outbreaks, Pandemics, Pneumonia, Viral
- Published
- 2020
- Full Text
- View/download PDF
150. Evidence and Recommendations on the Use of Telemedicine for the Management of Arterial Hypertension: An International Expert Position Paper.
- Author
-
Omboni S, McManus RJ, Bosworth HB, Chappell LC, Green BB, Kario K, Logan AG, Magid DJ, Mckinstry B, Margolis KL, Parati G, and Wakefield BJ
- Subjects
- Blood Pressure Determination methods, COVID-19, Coronavirus Infections epidemiology, Disease Management, Evidence-Based Medicine, Female, Humans, Hypertension diagnosis, Italy, Male, Occupational Health, Pandemics statistics & numerical data, Patient Safety, Pneumonia, Viral epidemiology, Severity of Illness Index, Coronavirus Infections prevention & control, Cross Infection prevention & control, Hypertension drug therapy, Pandemics prevention & control, Pneumonia, Viral prevention & control, Telemedicine statistics & numerical data
- Abstract
Telemedicine allows the remote exchange of medical data between patients and healthcare professionals. It is used to increase patients' access to care and provide effective healthcare services at a distance. During the recent coronavirus disease 2019 (COVID-19) pandemic, telemedicine has thrived and emerged worldwide as an indispensable resource to improve the management of isolated patients due to lockdown or shielding, including those with hypertension. The best proposed healthcare model for telemedicine in hypertension management should include remote monitoring and transmission of vital signs (notably blood pressure) and medication adherence plus education on lifestyle and risk factors, with video consultation as an option. The use of mixed automated feedback services with supervision of a multidisciplinary clinical team (physician, nurse, or pharmacist) is the ideal approach. The indications include screening for suspected hypertension, management of older adults, medically underserved people, high-risk hypertensive patients, patients with multiple diseases, and those isolated due to pandemics or national emergencies.
- Published
- 2020
- Full Text
- View/download PDF
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.